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Hepatocellular carcinoma (HCC) is the third leading cause of death by cancer
worldwide. The prognosis of patients with metastatic HCC remains limited, with an
expected median survival lower than 50% at 1 year. Here, we report the case of a
63-year-old man who suffered from a small HCC in the liver and a large unique
metastasis in the right adrenal gland. A surgical resection of both lesions was
performed. Seven months later, HCC recurred with an isolated right renal
metastatic lymphadenopathy and a high alpha-fetoprotein level. HCC was brought
under control by sorafenib; the alpha-fetoprotein level was greatly reduced but
remained moderately elevated and stable over 2 years after the onset of
chemotherapy. Additional external radiotherapy on the metastatic lymphadenopathy
led to a normalization of the alpha-fetoprotein level and discontinuation of sorafenib
treatment. One year after the end of radiotherapy, a second isolated metastasis
occurred in the right lung. This tumor was surgically removed. Twenty-one months
after this second surgical procedure, i.e., more than 5.5 years after the initial
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